Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence

Abstract

Introduction and Objectives: The efficacy of adjuvant and salvage external beam radiation (AXRT+SXRT) for prostate cancer after radical prostatectomy (RP) has been debated because of the inability to rule out systemic occult metastasis, uncertainty that radiation eradicates residual local disease and the potential of exacerbating impotency and incontinence. To characterize the effectiveness and treatment morbidity a retrospective review was performed.

Methods: In all, 38 patients received AXRT and 91 received SXRT. The SXRT group was stratified by PSA level, age, race, pathologic stage, margin status, worst Gleason sum, radiation dose and pelvic field. Complications evaluated were impotence and incontinence. Median follow-up was 60.2 months.

Results: The 5-y disease-free survival (DFS) rate was 61.3% for AXRT and 36.3% for SXRT. Multivariate analysis of the SXRT cohort showed Gleason score, pathologic stage and pre-XRT PSA to be predictors of disease recurrence. After XRT 26% had worsened continence.

Conclusions: Patients who recur after RP whose pathologic stage is pT2 or pT3c, Gleason score of 8 or higher or pre-XRT PSA is >2.0 ng/dl may have microscopic metastatic disease and a decreased chance of cure with SXRT alone. Continence was further impaired after XRT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Lu-Yao GL et al. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Canc Inst 1996; 88: 166–173.

    Article  CAS  Google Scholar 

  2. Cadeddu JA, Partin AW, DeWeese TL, Walsh PC . Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. J Urol 1998; 159: 173–178.

    Article  CAS  Google Scholar 

  3. Schild SE . Radiation therapy after prostatectomy: now or later? Semin Radiol Oncol 1998; 8: 132–139.

    Article  CAS  Google Scholar 

  4. Foreman JD et al. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 1997; 158: 1436–1440.

    Article  Google Scholar 

  5. Pisansky TM et al. Radiotherapy for isolated sereum prostate specific acid elevation after prostatectomy for prostate cancer. J Urol 2000; 163: 845–850.

    Article  CAS  Google Scholar 

  6. Anscher MS, Prosnitz LR . Multivariate analysis of factor predicting local relapse after radical prostatectomy: possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1991; 21: 941–947.

    Article  CAS  Google Scholar 

  7. Egawa S et al. Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy. BJU Int 1999; 84: 815–820.

    Article  CAS  Google Scholar 

  8. Schild SE et al. The results of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Rad Onc Biol Phys 1996; 34: 535–541.

    Article  CAS  Google Scholar 

  9. The New American Joint Commission on Cancer and International Union Against Cancer: TNM Classification of Prostate Cancer. Cancer 1994; 73: 104–114.

  10. Lowentritt BH et al. Sildenafil citrate after radical retropubic prostatectomy. J Urol 1999; 162: 1614–1617.

    Article  CAS  Google Scholar 

  11. Epstein JI et al. Prediction of progression following radical prostectomy: a multivariate analysis of 274 men with long-term follow up. Am J Surg Pathol 1996; 20: 286–292.

    Article  CAS  Google Scholar 

  12. Catalona WJ, Smith DS . Five year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994; 152: 1837–1842.

    Article  CAS  Google Scholar 

  13. Corn BW, Winter K, Pilepich MV . Does androgen supression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. Urology 1999; 54: 495–502.

    Article  CAS  Google Scholar 

  14. American Society for Therapeutic Radiology and Oncology Concensus Panel: Consensus Statements on Radiation Therapy of Prostate Cancer: Guidelines for re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. J Clin Oncol 1999; 17: 1155–1163.

  15. Formenti SC et al. Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparring prostatectomy. Urology 2000; 56: 453–458.

    Article  CAS  Google Scholar 

  16. Forman JD, Velasco J . Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology 1998; 12: 33–39.

    CAS  PubMed  Google Scholar 

  17. Morris MM et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 713–736.

    Article  Google Scholar 

  18. Valicenti RK et al. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology 1998; 52: 1034–1040.

    Article  CAS  Google Scholar 

  19. Van Cangh PJ et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol 1998; 159: 164–166.

    Article  CAS  Google Scholar 

  20. Stanford JL et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the prostate cancer outcomes study. JAMA 2000; 283: 354–360.

    Article  CAS  Google Scholar 

  21. Marks LB, Carrol PR, Dugan TC, Anscher MS . The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1995; 31: 1257–1280.

    Article  CAS  Google Scholar 

  22. Mulhall JP . Current concepts in erectile dysfunction. Am J Manage Car 2000; 6 (Suppl): s62.

    Google Scholar 

Download references

Acknowledgements

This research was supported by the following: The Center for Prostate Disease Research, a program of the Henry M Jackson Foundation for the Advancement of Military Medicine, 1401 Rockville Pike, Suite 600, Rockville, MD 20852-3001, funded by the US Army Medical Research and Materiel Command. This research was approved through the Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC, WU# 2857-98 and WU#2852-98.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J W Moul.

Additional information

The opinions and assertions contained herein are the private views of the authors and are not to be construed as reflecting the views of the US Army or the Department of Defense.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petroski, R., Warlick, W., Herring, J. et al. External beam radiation therapy after radical prostatectomy: efficacy and impact on urinary continence. Prostate Cancer Prostatic Dis 7, 170–177 (2004). https://doi.org/10.1038/sj.pcan.4500718

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500718

Keywords

This article is cited by

Search

Quick links